Full-Time

Manager – Financial Planning & Analysis

Research

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Mid

Cambridge, MA, USA

70% in-office structure required.

Category
Financial Planning and Analysis (FP&A)
Finance & Banking
Required Skills
SAP Products
Oracle
Requirements
  • Bachelor’s degree required
  • 5+ years’ experience in financial planning and analysis or accounting with a proven track record of success
  • Advanced degrees or certifications such as CPA, MBA, or CFA are preferred, yet required
  • Experience with tier 1 ERP systems (e.g. SAP, Oracle) and planning and reporting tools preferred
Responsibilities
  • In acting with urgency, partner the FP&A team in supporting R&D cost center owners by responding promptly to evolving financial needs and challenges, understanding that timely financial insights can impact future lives
  • Manage financial planning deliverables, such as quarterly forecasting, actuals reporting, variance analysis, annual budgeting, and long-range planning, while pursuing in parallel multiple avenues for budget allocation to make the most informed decisions down the line
  • Behaving like an owner, fostering business partnerships to enhance cross-functional transparency and efficiency of investments, actively encouraging agency and budget ownership among our business partners to achieve shared goals that exceed the typical scope of any single role
  • Accept risk and obsess over learning during month-end close support, including processing accruals and ensuring the accuracy of financial data, apply a learning mindset by troubleshooting complex issues and following up with accounting and business teams to improve future accuracy
  • Drive data validation and ad-hoc reconciliations to digitize everywhere possibly by leveraging digital tools and information to streamline processes, maximizing accuracy and impact on internal and external reporting outcomes
  • Handle invoicing, PO management, data structure, and reporting processes efficiently to ensure smooth, collaborative workflows with both internal stakeholders and external partners, aiming to remove viscosity and reduce friction in the financial process
  • Conduct ad-hoc analyses that support business decision-making, and contribute to process/system improvement initiatives, by pushing past the possible and embracing opportunities to challenge conventional approaches and uncover solutions that drive financial excellence

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?